$3.22 -0.28 (-8.00%)
2/10/2012 4:00 PM

Vical, Inc. (NASDAQ:VICL)

CAPS Rating: 3 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Featured Broker Partners


Advertisement